Found 6 hits for monomerid = 50220023 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Amine oxidase (flavin-containing) A
(Homo sapiens (Human)) | BDBM50220023
![PNG](/data/jpeg/tenK5022/BindingDB_50220023.png) ((5R)-3-{3-fluoro-4-[6-(1H-imidazol-1-ylacetyl)pyri...)Show SMILES Fc1cc(ccc1-c1ccc(nc1)C(=O)Cn1ccnc1)N1C[C@H](Cn2ccnn2)OC1=O Show InChI InChI=1S/C22H18FN7O3/c23-19-9-16(30-12-17(33-22(30)32)11-29-8-6-26-27-29)2-3-18(19)15-1-4-20(25-10-15)21(31)13-28-7-5-24-14-28/h1-10,14,17H,11-13H2/t17-/m0/s1 | PDB
UniProtKB/SwissProt UniProtKB/TrEMBL
antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| >1.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca Discovery
Curated by ChEMBL
| Assay Description Inhibition of human liver MAOA expressed in yeast |
J Med Chem 50: 4868-81 (2007)
Article DOI: 10.1021/jm070428+ BindingDB Entry DOI: 10.7270/Q2SX6CX0 |
More data for this Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50220023
![PNG](/data/jpeg/tenK5022/BindingDB_50220023.png) ((5R)-3-{3-fluoro-4-[6-(1H-imidazol-1-ylacetyl)pyri...)Show SMILES Fc1cc(ccc1-c1ccc(nc1)C(=O)Cn1ccnc1)N1C[C@H](Cn2ccnn2)OC1=O Show InChI InChI=1S/C22H18FN7O3/c23-19-9-16(30-12-17(33-22(30)32)11-29-8-6-26-27-29)2-3-18(19)15-1-4-20(25-10-15)21(31)13-28-7-5-24-14-28/h1-10,14,17H,11-13H2/t17-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca Discovery
Curated by ChEMBL
| Assay Description Inhibition of human recombinant CYP3A4 |
J Med Chem 50: 4868-81 (2007)
Article DOI: 10.1021/jm070428+ BindingDB Entry DOI: 10.7270/Q2SX6CX0 |
More data for this Ligand-Target Pair | |
Cytochrome P450 1A
(Homo sapiens (Human)) | BDBM50220023
![PNG](/data/jpeg/tenK5022/BindingDB_50220023.png) ((5R)-3-{3-fluoro-4-[6-(1H-imidazol-1-ylacetyl)pyri...)Show SMILES Fc1cc(ccc1-c1ccc(nc1)C(=O)Cn1ccnc1)N1C[C@H](Cn2ccnn2)OC1=O Show InChI InChI=1S/C22H18FN7O3/c23-19-9-16(30-12-17(33-22(30)32)11-29-8-6-26-27-29)2-3-18(19)15-1-4-20(25-10-15)21(31)13-28-7-5-24-14-28/h1-10,14,17H,11-13H2/t17-/m0/s1 | PDB MMDB
Reactome pathway KEGG
B.MOAD DrugBank GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca Discovery
Curated by ChEMBL
| Assay Description Inhibition of human recombinant CYP1A2 |
J Med Chem 50: 4868-81 (2007)
Article DOI: 10.1021/jm070428+ BindingDB Entry DOI: 10.7270/Q2SX6CX0 |
More data for this Ligand-Target Pair | |
Cytochrome P450 2D6
(Homo sapiens (Human)) | BDBM50220023
![PNG](/data/jpeg/tenK5022/BindingDB_50220023.png) ((5R)-3-{3-fluoro-4-[6-(1H-imidazol-1-ylacetyl)pyri...)Show SMILES Fc1cc(ccc1-c1ccc(nc1)C(=O)Cn1ccnc1)N1C[C@H](Cn2ccnn2)OC1=O Show InChI InChI=1S/C22H18FN7O3/c23-19-9-16(30-12-17(33-22(30)32)11-29-8-6-26-27-29)2-3-18(19)15-1-4-20(25-10-15)21(31)13-28-7-5-24-14-28/h1-10,14,17H,11-13H2/t17-/m0/s1 | PDB
UniProtKB/SwissProt UniProtKB/TrEMBL
GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca Discovery
Curated by ChEMBL
| Assay Description Inhibition of human recombinant CYP2D6 |
J Med Chem 50: 4868-81 (2007)
Article DOI: 10.1021/jm070428+ BindingDB Entry DOI: 10.7270/Q2SX6CX0 |
More data for this Ligand-Target Pair | |
Cytochrome P450 2C19
(Homo sapiens (Human)) | BDBM50220023
![PNG](/data/jpeg/tenK5022/BindingDB_50220023.png) ((5R)-3-{3-fluoro-4-[6-(1H-imidazol-1-ylacetyl)pyri...)Show SMILES Fc1cc(ccc1-c1ccc(nc1)C(=O)Cn1ccnc1)N1C[C@H](Cn2ccnn2)OC1=O Show InChI InChI=1S/C22H18FN7O3/c23-19-9-16(30-12-17(33-22(30)32)11-29-8-6-26-27-29)2-3-18(19)15-1-4-20(25-10-15)21(31)13-28-7-5-24-14-28/h1-10,14,17H,11-13H2/t17-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca Discovery
Curated by ChEMBL
| Assay Description Inhibition of human recombinant CYP2C19 |
J Med Chem 50: 4868-81 (2007)
Article DOI: 10.1021/jm070428+ BindingDB Entry DOI: 10.7270/Q2SX6CX0 |
More data for this Ligand-Target Pair | |
Cytochrome P450 2C9
(Homo sapiens (Human)) | BDBM50220023
![PNG](/data/jpeg/tenK5022/BindingDB_50220023.png) ((5R)-3-{3-fluoro-4-[6-(1H-imidazol-1-ylacetyl)pyri...)Show SMILES Fc1cc(ccc1-c1ccc(nc1)C(=O)Cn1ccnc1)N1C[C@H](Cn2ccnn2)OC1=O Show InChI InChI=1S/C22H18FN7O3/c23-19-9-16(30-12-17(33-22(30)32)11-29-8-6-26-27-29)2-3-18(19)15-1-4-20(25-10-15)21(31)13-28-7-5-24-14-28/h1-10,14,17H,11-13H2/t17-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 8.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca Discovery
Curated by ChEMBL
| Assay Description Inhibition of human recombinant CYP2C9 |
J Med Chem 50: 4868-81 (2007)
Article DOI: 10.1021/jm070428+ BindingDB Entry DOI: 10.7270/Q2SX6CX0 |
More data for this Ligand-Target Pair | |